Crescent Biopharma Stock (NASDAQ:CBIO)
Previous Close
$14.00
52W Range
$9.81 - $37.00
50D Avg
$12.58
200D Avg
$17.80
Market Cap
$209.50M
Avg Vol (3M)
$104.44K
Beta
1.49
Div Yield
-
CBIO Company Profile
Crescent Biopharma, Inc., an oncology company, develops therapies for cancer patients. Its pipeline includes a PD-1 x VEGF bispecific antibody, as well as novel antibody-drug conjugates to treat solid tumors. The company is headquartered in Waltham, Massachusetts.